Global Q Fever Market Professional Survey Report 2019

Q fever is a mild disease with flu-like symptoms. Many patients have no symptoms at all while in some cases; the infection can reoccur/resurface years later. The chronic Q fever is a more deadly form of Q fever which may damage heart, liver, brain, lungs and can cause diabetes in some cases.
The Americas account for the largest share in the global Q fever market owing to the presence of key players in the market and rising emphasis on diagnosis and treatment of rare diseases. Furthermore, the rising awareness about bacterial infection further accelerates the growth of the market. North America is the accounted for the highest market share in this region with the U.S. being the largest market followed by Canada. In the U.S, the prevalence of cardiovascular disease is found to be increasing from last few years. This is attributed to the rising prevalence of chronic diseases such as obesity and diabetes which are major risk factors for cardiovascular diseases.

The global Q Fever market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Q Fever volume and value at global level, regional level and company level. From a global perspective, this report represents overall Q Fever market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Q Fever in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Q Fever manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Yashica Pharmaceuticals Private Limited (India)
Merck & Co. (US)
Atox Bio (Israel)
Teva Pharmaceutical Industries (Israel)
Basilea Pharmaceutica Ltd. (Switzerland)
Pfizer (US)
Cipla Inc. (India)

Segment by Regions
North America
Southeast Asia

Segment by Type
Acute Q Fever
Chronic Q Fever

Segment by Application
Hospitals & Clinics
Diagnostic Centers
Surgical Centers

Frequently Asked Questions

This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.

  • By product type
  • By End User/Applications
  • By Technology
  • By Region

The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.

Please Select a Format

market Reports market Reports